473 related articles for article (PubMed ID: 26376206)
1. Development of in Silico Models for Predicting P-Glycoprotein Inhibitors Based on a Two-Step Approach for Feature Selection and Its Application to Chinese Herbal Medicine Screening.
Yang M; Chen J; Shi X; Xu L; Xi Z; You L; An R; Wang X
Mol Pharm; 2015 Oct; 12(10):3691-713. PubMed ID: 26376206
[TBL] [Abstract][Full Text] [Related]
2. ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates.
Li D; Chen L; Li Y; Tian S; Sun H; Hou T
Mol Pharm; 2014 Mar; 11(3):716-26. PubMed ID: 24499501
[TBL] [Abstract][Full Text] [Related]
3. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques.
Chen L; Li Y; Zhao Q; Peng H; Hou T
Mol Pharm; 2011 Jun; 8(3):889-900. PubMed ID: 21413792
[TBL] [Abstract][Full Text] [Related]
4. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein.
Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K
Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526
[TBL] [Abstract][Full Text] [Related]
5. QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase.
Shameera Ahamed TK; Rajan VK; Sabira K; Muraleedharan K
Comput Biol Chem; 2018 Dec; 77():154-166. PubMed ID: 30321850
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of Chinese herbs with Random Forest.
Ehrman TM; Barlow DJ; Hylands PJ
J Chem Inf Model; 2007; 47(2):264-78. PubMed ID: 17381165
[TBL] [Abstract][Full Text] [Related]
7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods.
Yang XG; Lv W; Chen YZ; Xue Y
J Comput Chem; 2010 Apr; 31(6):1249-58. PubMed ID: 19847781
[TBL] [Abstract][Full Text] [Related]
9. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
10. [Application of support vector machine in screening neurotoxic compounds from traditional Chinese medicine].
Zhang JF; Jiang LD; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3330-4. PubMed ID: 25522622
[TBL] [Abstract][Full Text] [Related]
11. Prediction of P-glycoprotein substrates by a support vector machine approach.
Xue Y; Yap CW; Sun LZ; Cao ZW; Wang JF; Chen YZ
J Chem Inf Comput Sci; 2004; 44(4):1497-505. PubMed ID: 15272858
[TBL] [Abstract][Full Text] [Related]
12. Prediction Methods of Herbal Compounds in Chinese Medicinal Herbs.
Han K; Zhang L; Wang M; Zhang R; Wang C; Zhang C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30201875
[TBL] [Abstract][Full Text] [Related]
13. Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
Fang J; Yang R; Gao L; Zhou D; Yang S; Liu AL; Du GH
J Chem Inf Model; 2013 Nov; 53(11):3009-20. PubMed ID: 24144102
[TBL] [Abstract][Full Text] [Related]
14. Predicting human liver microsomal stability with machine learning techniques.
Sakiyama Y; Yuki H; Moriya T; Hattori K; Suzuki M; Shimada K; Honma T
J Mol Graph Model; 2008 Feb; 26(6):907-15. PubMed ID: 17683964
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
[TBL] [Abstract][Full Text] [Related]
16. Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors.
Klepsch F; Vasanthanathan P; Ecker GF
J Chem Inf Model; 2014 Jan; 54(1):218-29. PubMed ID: 24050383
[TBL] [Abstract][Full Text] [Related]
17. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
[TBL] [Abstract][Full Text] [Related]
18. Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds.
Ngo TD; Tran TD; Le MT; Thai KM
Mol Divers; 2016 Nov; 20(4):945-961. PubMed ID: 27431577
[TBL] [Abstract][Full Text] [Related]
19. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
20. Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds.
Mora Lagares L; Minovski N; Novič M
Molecules; 2019 May; 24(10):. PubMed ID: 31130601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
